scholarly journals Effects of Socioeconomic Status and Health Care Access on Low Levels of Human Papillomavirus Vaccination Among Spanish-Speaking Hispanics in California

2013 ◽  
Vol 103 (2) ◽  
pp. 270-272 ◽  
Author(s):  
Shingisai Chando ◽  
Jasmin A. Tiro ◽  
T. Robert Harris ◽  
Sarah Kobrin ◽  
Nancy Breen
Keyword(s):  
Health Care ◽  
Socioeconomic Status ◽  
Human Papillomavirus ◽  
Health Care Access ◽  
Human Papillomavirus Vaccination ◽  
Spanish Speaking ◽  
Care Access ◽  
Low Levels ◽  
Socioeconomic Status And Health

scholarly journals Race, Socioeconomic Status, and Health-Care Access Disparities in Ovarian Cancer Treatment and Mortality: Systematic Review and Meta-Analysis

2019 ◽  
Vol 3 (4) ◽  
Author(s):  
Shama Karanth ◽  
Mackenzie E Fowler ◽  
XiHua Mao ◽  
Lauren E Wilson ◽  
Bin Huang ◽  
...  
Keyword(s):  
Systematic Review ◽  
Ovarian Cancer ◽  
Health Care ◽  
Socioeconomic Status ◽  
Cancer Treatment ◽  
Health Care Access ◽  
Meta Analysis ◽  
The United States ◽  
Care Access

Abstract Background Ovarian cancer remains a leading cause of death from gynecological malignancies. Race, socioeconomic status (SES), and access to health care are important predictors of quality treatment and survival. We provide a systematic review and meta-analysis on the role of these predictors on disparities in ovarian cancer treatment and mortality. Methods Using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, we searched PubMed, EMBASE, and Scopus for relevant articles published between January 2000 and March 2017. We selected studies published in the United States that evaluated the role of race, SES, or health-care access on disparities in ovarian cancer treatment or survival. Pooled relative risk (RR) and 95% confidence intervals (CIs) were calculated for each outcome using a random-effects model. Results A total of 41 studies met the inclusion criteria for systematic review. In meta-analysis, there was a 25% decrease (RR = 0.75, 95% CI = 0.66 to 0.84) in receipt of adherent ovarian cancer treatment and 18% increased risk (RR = 1.18, 95% CI = 1.11 to 1.26) of mortality for blacks compared to whites. Receipt of adherent ovarian cancer treatment was 15% lower (RR = 0.85, 95% CI = 0.77 to 0.94) in the lowest vs highest SES group and 30% lower (RR = 0.70, 95% CI = 0.58 to 0.85) among patients at lower vs higher hospital volumes. Conclusion We found consistent and strong evidence for continued lack of quality ovarian cancer treatment and higher mortality among ovarian cancer patients who are black, are of low SES, and/or have poor access to care. Interventions focused on these groups targeting specific barriers to care are needed to reduce disparities in ovarian cancer treatment and mortality.

Sign in / Sign up

Export Citation Format

Share Document